Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AKTS vs MRAM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MRAM Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

MRAM Overall Winner 6-Pillar Tally: AKTS 0 – 6 MRAM Matrix Metrics: AKTS 2 – 8 MRAM

As of Nov 16, 2026, Everspin Technologies, Inc (MRAM) is the stronger overall head-to-head candidate over AKTS (AKTS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AKTS carries a Unified Composite Score of 30.6/100 (SELL) at $16.55 (N/M Forward P/E, N/A operating margin), whereas MRAM carries 54.4/100 (HOLD) at $11.44 (21.3x Forward P/E, -23.3% operating margin).

  • Technical & Structure Timing Caution: AKTS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.1); meanwhile MRAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AKTS vs MRAM
AKTS US Equity
AKTS
Institutional Equity
$16.55
-0.42% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.35β · 67% Vol
Unified Composite Score
30.6 / 100 SELL
Tech 20.0 Fund 36.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.1 · SMA20: $16.12 · SMA50: $18.33
MRAM NASDAQ Head-to-Head Winner
Everspin Technologies, Inc
Semiconductors & Related Devices
$11.44
-6.61% 1D
Market Cap $296.9M
TTM Revenue $69M
Forward P/E 21.3x
Beta / 30D Vol 4.49β · 108% Vol
Unified Composite Score
54.4 / 100 HOLD
Tech 50.0 Fund 60.0 Flow 69.0 Mom 78.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 39
RSI-14: 38.7 · SMA20: $12.95 · SMA50: $15.00

6-Pillar Scorecard Institutional Category Breakdown (AKTS 0 – 6 MRAM)

Columns: Metric · AKTS · MRAM
1. Valuation Multiples MRAM
Forward P/E N/M 21.3x
Trailing P/E N/M 19.6x
PEG Ratio N/M N/M
EV / Revenue N/M 4.3x
2. Growth & Scale MRAM
Revenue Growth (YoY) N/A +46.9%
Earnings Growth (YoY) N/A -10.8%
TTM Revenue (USD) N/A $69M
Market Cap N/A $296.9M
3. Profitability & Quality MRAM
Gross Margin N/A 52.2%
Operating Margin N/A -23.3%
Net Profit Margin N/A -14.3%
Return on Equity (ROE) N/A -14.8%
4. Balance Sheet & Cash Flow MRAM
Cash Generation (TTM) N/A -$15M EBITDA
Cash Flow Margin N/A -21.9% EBITDA Mgn
Net Cash / Leverage N/A ROE $2.77 Book/Sh · -14.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning MRAM
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 95.4% (29th %ile)
Put/Call OI Skew N/A 0.65x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat MRAM
OpEx & R&D Intensity N/A 75.5% of Rev ($52M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Semiconductors Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AKTS (2) vs MRAM (8)
Institutional Metric AKTS MRAM Criterion Row Edge
Market Capitalization
Scale
N/A $296.9M Larger Scale MRAM
Trailing P/E Ratio
Valuation
N/M 19.6x Lower Multiple MRAM
Forward P/E Ratio
Valuation
N/M 21.3x Lower Multiple MRAM
Revenue Growth (YoY)
Growth
N/A +46.9% Higher Growth MRAM
Operating Margin (TTM)
Profitability
N/A -23.3% Higher Margin MRAM
Net Profit Margin
Profitability
N/A -14.3% Higher Margin MRAM
Return on Equity (ROE)
Capital Efficiency
N/A -14.8% Higher ROE MRAM
52-Week Range Position
Momentum
13% ($14–$34) 9% ($7–$52) Stronger Trend AKTS
Beta / 30D Volatility
Risk Regime
1.35β · 67% Vol 4.49β · 108% Vol Lower Realized Risk AKTS
Unified Institutional Score
Composite Signal
30.6 / 100 (SELL) 54.4 / 100 (HOLD) Higher Composite MRAM
Trailing 12M Revenue (USD)
Operating Scale
N/A $69M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 52.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 4.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$15M EBITDA ($2.77 Book/Sh · -14.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AKTS +22.03 pp
AKTS: +9.89% · MRAM: -12.14%
3M Horizon AKTS +4.19 pp
AKTS: -33.8% · MRAM: -37.99%
6M Horizon AKTS +54.63 pp
AKTS: -11.07% · MRAM: -65.7%
1Y Horizon MRAM +21.29 pp
AKTS: -26.12% · MRAM: -4.83%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKTS vs MRAM. Trailing 12-month operating profitability (AKTS N/A vs MRAM -23.3%) and valuation multiples (AKTS N/M vs MRAM 21.3x Forward P/E) are benchmarked directly in Pillar 4 below.

AKTS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
MRAM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$69M
Gross Margin52.2%
Op. Margin-23.3%
ROE / Fwd P/E-14.8% · 21.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AKTS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AKTS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MRAM BREAKDOWN
130d in phase · OBV NEUTRAL
Current IV 95.4%
IV Percentile 29th %ile
Put/Call OI Skew 0.65x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact MRAM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AKTS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
MRAM Moat Profile Cyclical / Execution-Driven Positioning
Semiconductors Operator
Competes within the Semiconductors value chain with $296.9M market capitalization and -23.3% operating margin.
OpEx & R&D Reinvestment 75.5% of Rev ($52M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
GLOBALFOUNDRIES Taiwan Semiconductor Manufacturing Company Tower Semiconductor ASE Technology Holding

Investor FAQ AKTS vs MRAM Key Questions & Quantitative Answers

As of Nov 16, 2026, Everspin Technologies, Inc (MRAM) is the stronger overall head-to-head candidate over AKTS (AKTS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AKTS carries a Unified Composite Score of 30.6/100 (SELL) at $16.55 (N/M Forward P/E, N/A operating margin), whereas MRAM carries 54.4/100 (HOLD) at $11.44 (21.3x Forward P/E, -23.3% operating margin). Technical & Structure Timing Caution: AKTS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.1); meanwhile MRAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MRAM leads the Growth & Scale pillar: AKTS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MRAM at +46.9% YoY revenue growth and -10.8% YoY earnings growth on $69M TTM revenue (52.2% gross margin, -23.3% operating margin). On trailing 12-month operating scale, AKTS generates N/A in USD-normalized revenue versus $69M for MRAM. In operating R&D and SG&A reinvestment, AKTS deploys N/A (0 90-day corporate R&D disclosures) versus 75.5% of Rev ($52M) (0 disclosures) for MRAM.

MRAM screens cheaper on headline valuation multiples. AKTS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MRAM trades at 21.3x Forward P/E, 19.6x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (-21.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AKTS (N/A ROE) versus MRAM (-14.8% ROE) capital efficiency.

In options market volatility and institutional positioning, AKTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.35β · 67% Vol realized risk). By comparison, MRAM carries 95.4% implied volatility (29th %ile, Balanced (25th–60th %ile)), a 0.65x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.49β · 108% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.